Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Benobio Co., Ltd.

Clinical trials sponsored by Benobio Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drug BBC1501 enters first human safety trial for blinding disease Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New eye drug BBC1501 enters first human safety trial for blinding disease

Disease control Recruiting now

This early-stage trial tests an experimental drug called BBC1501, given as an injection into the eye, for people with wet age-related macular degeneration (nAMD). The main goal is to check safety and tolerability in 18 volunteers aged 50 and older who have already received standa…

Phase 1 • Sponsor: Benobio Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC